Drug-eluting stents for the treatment of coronary artery disease

  • Technology appraisal guidance
  • TA152
  • Published: 
  • Last updated: 
Download guidance (PDF)

Appendix B: Sources of evidence considered by the Committee

A. The assessment report for this appraisal was prepared by Liverpool Reviews and Implementation Group, University of Liverpool.

  • Hill R, Boland A, Dickson R, et al. Drug-eluting stents: a systematic review and economic evaluation, November 2005

B. The following organisations accepted the invitation to participate in this appraisal. They were invited to comment on the draft scope, assessment report and the appraisal consultation document (ACD). Organisations listed in I and II were also invited to make written submissions and have the opportunity to appeal against the final appraisal determination.

I) Manufacturers/sponsors:

  • Abbott Vascular Devices Ltd

  • Biotronik UK Ltd

  • Boston Scientific

  • Cordis Corporation

  • Guidant

  • Kiwimed Ltd

  • Medtronic AVE

  • Sorin Biomedica UK Ltd

II) Professional/specialist and patient/carer groups:

  • British Association for Nursing in Cardiac Care

  • British Cardiac Society

  • British Cardiovascular Intervention Society

  • British Heart Foundation

  • Royal College of Nursing

  • Royal College of Physicians

  • Royal College of Physicians of Edinburgh

  • Pharmaceutical Society of Great Britain

  • Society for Cardiological Science and Technology

  • Society of Cardiothoracic Surgeons of Great Britain and Ireland

  • Action Heart

  • British Cardiac Patients Association

  • Coronary Prevention Group

  • HEART UK

  • National Heart Forum

  • Heart Care Partnership (UK)

III) Other consultees

  • Barnet PCT

  • Central Derby PCT

  • Department of Health

  • Welsh Assembly Government

IV) Commentator organisations (without the right of appeal):

  • Association of British Health-Care Industries (ABHI)

  • British Cardiovascular Industry Association (BCIA)

  • Board of Community Health Councils in Wales

  • British National Formulary

  • EUCOMED

  • Medicines and Healthcare products Regulatory Agency (MHRA)

  • National Collaborating Centre for Acute Care

  • National Collaborating Centre for Chronic Conditions

  • National Public Health Service for Wales

  • NHS Confederation

  • NHS Purchasing and Supplies Agency

  • NHS Quality Improvement Scotland

C. The following individuals were selected from clinical specialist and patient advocate nominations from the non-manufacturer/sponsor consultees and commentators. They participated in the Appraisal Committee discussions and provided evidence to inform the Appraisal Committee's deliberations. They gave their expert personal view on drug-eluting stents by attending the initial Committee discussion and/or providing written evidence to the Committee. They were also invited to comment on the ACD.

  • Mrs Jill Bishop, Cardiac Catheter Theatre Manager, nominated by the British Association of Nursing in Cardiac Care – clinical specialist (attended in 2006 and 2007).

  • Mr Ron Box, nominated by the Heart Care Partnership – patient expert (attended in 2006 and 2007).

  • Dr Martyn Thomas, Consultant Cardiologist, nominated by the British Cardiovascular Intervention Society – clinical specialist (attended in 2006 and 2007).

  • Dr AH Gershlick, Consultant Cardiologist, nominated by the British Heart Foundation and the British Cardiac Society – clinical specialist (ttended in 2006 and 2007).

  • Dr Keith Oldroyd, Consultant Cardiologist, nominated by NHS Quality Improvement Scotland – clinical specialist (attended in 2006 and 2007).

  • Rev Dan Paterson, nominated by the Heart Care Partnership – patient expert (attended in 2006).

  • Ms Liz Clarke, nominated by the Heart Care Partnership – patient expert (attended in 2007).